Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.114142
Revised: October 27, 2025
Accepted: January 8, 2026
Published online: March 25, 2026
Processing time: 183 Days and 8.5 Hours
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain management, but they can cause nephrotoxicity, particularly in patients with existing renal impairment. Cerium oxide (CeO2), an antioxidant nanoparticle, may provide protection against renal damage caused by NSAIDs.
To assess the protective effects of CeO2 against ibuprofen-induced renal injury in a rat model of unilateral ureteral obstruction (UUO).
Thirty male Wistar albino rats, weighing between 300 g and 425 g, were randomly divided into five groups (n = 6 each): Control (sham), UUO only, UUO + ibupro
In the right (non-obstructed) kidneys, the UUO + CeO2 group exhibited significantly lower levels of GV, tubular hyaline casts, and tubular desquamation compared to the UUO + ibuprofen group (P < 0.05). In the left (obstructed) kidneys, the CeO2-treated group also exhibited significant reductions in GV, vascular hypertrophy, and tubular hyaline casts (P < 0.05). Furthermore, malondialdehyde levels were markedly decreased in the CeO2 groups, whereas nitric oxide levels were elevated in the ibuprofen group. Blood urea nitrogen and creatinine levels increased across all UUO groups, but no significant differences were observed between the treatment groups.
CeO2 attenuates ibuprofen-induced renal injury in rats with UUO, likely through antioxidative mechanisms. These findings suggest that CeO2 could serve as a potential nephroprotective adjunct during NSAID therapy in patients with obstructive renal conditions.
Core Tip: This experimental study explores the protective effects of cerium oxide (CeO2), a powerful antioxidant nanoparticle, against renal injury induced by ibuprofen in rats with unilateral ureteral obstruction. Histopathological and biochemical analyses demonstrated that CeO2 significantly reduced tubular degeneration, glomerular vacuolization, and oxidative stress markers in both the obstructed and contralateral kidneys. These results indicate that CeO2 may function as a nephroprotective adjunct during non-steroidal anti-inflammatory drug therapy, potentially mitigating renal damage associated with obstructive uropathy.
